15902
19712
Nippon India Pharma Fund - Direct (G)
22.54
9.50
13.73
2.45
6.46
16.52
10.62
17.73
https://storage.googleapis.com/5paisa-prod-storage/files/2024-06/nippon-india-mf_0.png
7
1.9
13.73
Nippon India Pharma Fund - Direct (G)
1.82
12.71
1.19
3.5
5 Years
Nippon India Pharma Fund - Direct (G)
Invest in Mutual Funds at 0 Transaction cost
-
NAV
633.82
03 Jul 2026
-
1.21%
1 Day
-
22.54%
3Y CAGR returns
Note: Data shown is for Direct Plan. Our Platform offers Regular Plans only.
Returns may differ due to expense ratio differences.
One click to compare funds with our smart tool—analyze returns & more!
Compare
-
₹ 100
Min SIP -
₹ 5000
Min Lumpsum -
1.02%
Expense Ratio -
8,636 Cr
Fund Size -
13 Years
Fund Age
Returns and Ranks ( as on 03 Jul 2026 )
- 1Y Returns
- 3Y Returns
- 5Y Returns
- MAX Returns
- Trailing Returns
- 9.50%
- 22.54%
- 13.73%
- 17.73
- 16.16Alpha
- 4.56SD
- 0.71Beta
- 1.08Sharpe
- Exit Load
- 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
- Tax implication
- Returns redeemed within a year are taxed at 20%, while those held longer incur a 12.5% LTCG tax on gains over Rs 1.25 lakh per financial year.
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
Low
Low to
moderate Moderate Moderately
High High Very
High
moderate Moderate Moderately
High High Very
High
- Address :
- 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
-
- Contact :
- +91022-68087000/1860260111
-
- Email ID :
- customercare@nipponindiaim.in
Other Calculators
FAQs
Nippon India Pharma Fund - Direct (G) has delivered 18.85% since inception
The NAV of Nippon India Pharma Fund - Direct (G) is ₹511.22 as of 03 Jul 2026
The expense ratio of Nippon India Pharma Fund - Direct (G) is 1.02 % as of 03 Jul 2026
The AUM of Nippon India Pharma Fund - Direct (G) 7160.93 CR as of 03 Jul 2026
The minimum SIP amount of Nippon India Pharma Fund - Direct (G) is 100
The top stock holdings of Nippon India Pharma Fund - Direct (G) are
- Sun Pharma.Inds. - 13.35%
- Lupin - 7.31%
- Dr Reddy's Labs - 6.72%
- Cipla - 6.16%
- Divi's Lab. - 5.80%
The top sectors Nippon India Pharma Fund - Direct (G) has invested in are
- Pharmaceuticals & Biotech - 77.63%
- Healthcare Services - 17.57%
- Retailing - 3.14%
- Debt - 1.79%
- Cash & Others - -0.13%